Search Results - "GARCIA GARCIA, Hector"

Impact of statin therapy on coronary plaque composition: a systematic review and meta-analysis of virtual histology intravascular ultrasound studies by Banach, Maciej, Serban, Corina, Sahebkar, Amirhossein, Mikhailidis, Dimitri P, Ursoniu, Sorin, Ray, Kausik K, Rysz, Jacek, Toth, Peter P, Muntner, Paul, Mosteoru, Svetlana, García-García, Hector M, Hovingh, G Kees, Kastelein, John J P, Serruys, Patrick W

“…Virtual histology intravascular ultrasound (VH-IVUS) imaging is an innovative tool for the morphological evaluation of coronary atherosclerosis. Evidence for…”
Get full text

Ultrathin bioresorbable polymer sirolimus-eluting stents in US patients undergoing coronary revascularization: 1-Year outcomes from the BIOFLOW VII trial by Kandzari, David E, Garcia-Garcia, Hector M, Stoler, Robert C, Wang, John, Picone, Mark, Ben-Dor, Itsik, Garcia, Santiago A

“…Ultrathin strut coronary drug-eluting stents (DES) have demonstrated improved safety and efficacy in large contemporary trials. The evaluation of an ultrathin…”
Get full text

A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial by Serruys, Patrick W, Prof, Chevalier, Bernard, MD, Dudek, Dariusz, MD, Cequier, Angel, MD, Carrié, Didier, MD, Iniguez, Andres, MD, Dominici, Marcello, MD, van der Schaaf, René J, MD, Haude, Michael, MD, Wasungu, Luc, PhD, Veldhof, Susan, RN, Peng, Lei, MSc, Staehr, Peter, MD, Grundeken, Maik J, MD, Ishibashi, Yuki, MD, Garcia-Garcia, Hector M, MD, Onuma, Yoshinobu, MD

“…Summary Background Despite rapid dissemination of an everolimus-eluting bioresorbable scaffold for treatment for coronary artery disease, no data from…”
Get full text

Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trial by Haude, Michael, Prof, Ince, Hüseyin, Prof, Abizaid, Alexandre, MD, Toelg, Ralph, MD, Lemos, Pedro Alves, MD, von Birgelen, Clemens, Prof, Christiansen, Evald Høj, MD, Wijns, William, MD, Neumann, Franz-Josef, Prof, Kaiser, Christoph, MD, Eeckhout, Eric, Prof, Lim, Soo Teik, Prof, Escaned, Javier, MD, Garcia-Garcia, Hector M, MD, Waksman, Ron, MD

“…Summary Background Absorbable scaffolds were designed to overcome the limitations of conventional, non-absorbable metal-based drug-eluting stents. So far, only…”
Get full text

Long-term ticagrelor monotherapy versus standard dual antiplatelet therapy followed by aspirin monotherapy in patients undergoing biolimus-eluting stent implantation: rationale and design of the GLOBAL LEADERS trial by Vranckx, Pascal, Valgimigli, Marco, Windecker, Stephan, Steg, Philippe, Hamm, Christian, Jüni, Peter, Garcia-Garcia, Hector, van Es, Gerrit, Serruys, Patrick

Get full text

Safety and clinical performance of a drug eluting absorbable metal scaffold in the treatment of subjects with de novo lesions in native coronary arteries: Pooled 12‐month outcomes of BIOSOLVE‐II and BIOSOLVE‐III by Haude, Michael, Ince, Hüseyin, Kische, Stephan, Abizaid, Alexandre, Tölg, Ralph, Alves Lemos, Pedro, Van Mieghem, Nicolas M., Verheye, Stefan, von Birgelen, Clemens, Christiansen, Evald Høj, Barbato, Emanuele, Garcia‐Garcia, Hector M., Waksman, Ron

“…Objectives Based on outcomes of the BIOSOLVE‐II study, a novel second generation drug‐eluting absorbable metal scaffold gained CE‐mark in 2016. The…”
Get full text

Thin-cap fibroatheroma predicts clinical events in diabetic patients with normal fractional flow reserve: the COMBINE OCT-FFR trial by Kedhi, Elvin, Berta, Balazs, Roleder, Tomasz, Hermanides, Renicus S, Fabris, Enrico, IJsselmuiden, Alexander J J, Kauer, Floris, Alfonso, Fernando, von Birgelen, Clemens, Escaned, Javier, Camaro, Cyril, Kennedy, Mark W, Pereira, Bruno, Magro, Michael, Nef, Holger, Reith, Sebastian, Al Nooryani, Arif, Rivero, Fernando, Malinowski, Krzysztof, De Luca, Giuseppe, Garcia Garcia, Hector, Granada, Juan F, Wojakowski, Wojciech

“…The aim of this study was to understand the impact of optical coherence tomography (OCT)-detected thin-cap fibroatheroma (TCFA) on clinical outcomes of…”
Get full text

Drug-Coated Balloon for De Novo Coronary Artery Disease: JACC State-of-the-Art Review by Yerasi, Charan, Case, Brian C, Forrestal, Brian J, Torguson, Rebecca, Weintraub, William S, Garcia-Garcia, Hector M, Waksman, Ron

“…Percutaneous coronary intervention with a drug-eluting stent is the most common mode of revascularization for coronary artery disease. However, restenosis…”
Get full text

Angiography‐derived versus invasively‐determined index of microcirculatory resistance in the assessment of coronary microcirculation: A systematic review and meta‐analysis by Fernández‐Peregrina, Estefania, Garcia‐Garcia, Hector M., Sans‐Rosello, Jordi, Sanz‐Sanchez, Jorge, Kotronias, Rafail, Scarsini, Roberto, Echavarria‐Pinto, Mauro, Tebaldi, Matteo, De Maria, Giovanni L.

“…Background The index of microvascular resistance (IMR) is an established tool to assess the status of coronary microcirculation. However, the need for a…”
Get full text

Standardized End Point Definitions for Coronary Intervention Trials by Garcia-Garcia, Hector M, McFadden, Eugène P, Farb, Andrew, Mehran, Roxana, Stone, Gregg W, Spertus, John, Onuma, Yoshinobu, Morel, Marie-angèle, van Es, Gerrit-Anne, Zuckerman, Bram, Fearon, William F, Taggart, David, Kappetein, Arie-Pieter, Krucoff, Mitchell W, Vranckx, Pascal, Windecker, Stephan, Cutlip, Donald, Serruys, Patrick W

“…Abstract The Academic Research Consortium (ARC)-2 initiative revisited the clinical and angiographic end point definitions in coronary device trials, proposed…”
Get full text

Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document by Garcia-Garcia, Hector M, McFadden, Eugène P, Farb, Andrew, Mehran, Roxana, Stone, Gregg W, Spertus, John, Onuma, Yoshinobu, Morel, Marie-angèle, van Es, Gerrit-Anne, Zuckerman, Bram, Fearon, William F, Taggart, David, Kappetein, Arie-Pieter, Krucoff, Mitchell W, Vranckx, Pascal, Windecker, Stephan, Cutlip, Donald, Serruys, Patrick W

“…The Academic Research Consortium (ARC)-2 initiative revisited the clinical and angiographic end point definitions in coronary device trials, proposed in 2007,…”
Get full text

Standardized classification and framework for reporting, interpreting, and analysing medication non-adherence in cardiovascular clinical trials: a consensus report from the Non-adherence Academic Research Consortium (NARC) by Valgimigli, Marco, Garcia-Garcia, Hector M, Vrijens, Bernard, Vranckx, Pascal, McFadden, Eugène P, Costa, Francesco, Pieper, Karen, Vock, David M, Zhang, Min, Van Es, Gerrit-Anne, Tricoci, Pierluigi, Baber, Usman, Steg, Gabriel, Montalescot, Gilles, Angiolillo, Dominick J, Serruys, Patrick W, Farb, Andrew, Windecker, Stephan, Kastrati, Adnan, Colombo, Antonio, Feres, Fausto, Jüni, Peter, Stone, Gregg W, Bhatt, Deepak L, Mehran, Roxana, Tijssen, Jan G P

“…Non-adherence has been well recognized for years to be a common issue that significantly impacts clinical outcomes and health care costs. Medication adherence…”
Get full text

A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods by Serruys, Patrick W, Prof, Ormiston, John A, Prof, Onuma, Yoshinobu, MD, Regar, Evelyn, MD, Gonzalo, Nieves, MD, Garcia-Garcia, Hector M, MD, Nieman, Koen, MD, Bruining, Nico, PhD, Dorange, Cécile, MSc, Miquel-Hébert, Karine, PhD, Veldhof, Susan, RN, Webster, Mark, MB, Thuesen, Leif, MD, Dudek, Dariusz, MD

“…Summary Background Drug-eluting metallic coronary stents predispose to late stent thrombosis, prevent late lumen vessel enlargement, hinder surgical…”
Get full text

Age and functional relevance of coronary stenosis: a post hoc analysis of the ADVISE II trial by Faria, Daniel Candeias, Lee, Joo Myung, van der Hoef, Tim, Mejía-Rentería, Hernán, Echavarría-Pinto, Mauro, Baptista, Sérgio Bravo, Cerrato, Enrico, Garcia-Garcia, Hector M, Davies, Justin, Onuma, Yoshinobu, Samady, Habib, Piek, Jan J, Serruys, Patrick W, Lerman, Amir, Escaned, Javier

“…The influence of age-dependent changes on fractional flow reserve (FFR) or instantaneous wave-free ratio (iFR) and the response to pharmacological hyperaemia…”
Get full text

Changes in Coronary Plaque Composition in Patients With Acute Myocardial Infarction Treated With High-Intensity Statin Therapy (IBIS-4): A Serial Optical Coherence Tomography Study by Räber, Lorenz, Koskinas, Konstantinos C, Yamaji, Kyohei, Taniwaki, Masanori, Roffi, Marco, Holmvang, Lene, Garcia Garcia, Hector M, Zanchin, Thomas, Maldonado, Rafaela, Moschovitis, Aris, Pedrazzini, Giovanni, Zaugg, Serge, Dijkstra, Jouke, Matter, Christian M, Serruys, Patrick W, Lüscher, Thomas F, Kelbaek, Henning, Karagiannis, Alexios, Radu, Maria D, Windecker, Stephan

“…This study assessed changes in optical coherence tomography (OCT)-defined plaque composition in patients with ST-elevation myocardial infarction (STEMI)…”
Get full text

Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial by Kandzari, David E, Mauri, Laura, Koolen, Jacques J, Massaro, Joseph M, Doros, Gheorghe, Garcia-Garcia, Hector M, Bennett, Johan, Roguin, Ariel, Gharib, Elie G, Cutlip, Donald E, Waksman, Ron

“…The development of coronary drug-eluting stents has included use of new metal alloys, changes in stent architecture, and use of bioresorbable polymers. Whether…”
Get full text

Effect of Statin Therapy on Fibrous Cap Thickness in Coronary Plaque on Optical Coherence Tomography　― Review and Meta-Analysis by Ozaki, Yuichi, Garcia-Garcia, Hector M., Beyene, Solomon S., Hideo-Kajita, Alexandre, Kuku, Kayode O., Kolm, Paul, Waksman, Ron

“…Background:Statin therapy has been shown to result in coronary plaque regression, but the relationship between statin use and stabilization of coronary plaque…”
Get full text

Lipid-rich plaque density and low-density lipoprotein cholesterol in statin-treated versus statin-naïve patients: a post hoc analysis of the LRP study by Torguson, Rebecca, Mintz, Gary S, Zhang, Cheng, Case, Brian C, Di Mario, Carlo, Garcia-Garcia, Hector M, Waksman, Ron

Get full text

A prospective, first-in-human use of the NeVa mechanical thrombectomy device for patients with acute coronary syndromes by Spirito, Alessandro, Quagliana, Angelo, Coiro, Marco, Melaku, Gebremedhin D, Vandenberghe, Stijn, Leibundgut, Gregor, Häner, Jonas, Moccetti, Marco, Araco, Marco, Garcia-Garcia, Hector M, Valgimigli, Marco

“…There is no established technique for managing large thrombus burden (LTB) in patients with acute coronary syndrome (ACS). The aim of this study was to assess…”
Get full text

Optical coherence tomography assessment of acute thrombogenicity at bifurcation sites using different stenting techniques: A porcine arteriovenous shunt study by Dan, Kazuhiro, Bhogal, Sukhdeep, Kuku, Kayode O., Melaku, Gebremedhin D., Devineni, Aditya, Hellinga, David, Waksman, Ron, Garcia‐Garcia, Hector M.

“…Objectives We aimed to compare bare‐metal stents (BMS), durable‐polymer everolimus‐eluting stents (DP‐EES), and abluminal biodegradable‐polymer…”
Get full text